PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 15, 20240 citationsOpen Access

Supplementary Figure S2 from First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors

View Full Paper
TYTimothy A. YapATAnthony W. TolcherRPRuth Plummer

Key Points

Key points are not available for this paper at this time.

Abstract

Figure S2. Change from baseline in tumor size and tuvusertib dose levels (FAS/SAF Analysis Set)

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yap et al. (2024) studied this question.

synapsesocial.com/papers/68e6a14db6db643587624fbchttps://doi.org/10.1158/1078-0432.25826657
Ask AI
Helpful
Bookmark
Share
View Full Paper